NEW ALLIANCE CAPITAL
New Alliance Capital is a venture capital and private equity firm that specializes in early, growth stage and pre-IPO investments. It primarily invest in high-end manufacturing, technology, advanced agriculture, consumer goods, information, media, energy, recycling, environmental protection, and modern services industry sectors. New Alliance Capital typically invests between $4.71 million and $31.41 million. Qu Liefeng founded it in 2008, with its headquarters in Shanghai in China.
NEW ALLIANCE CAPITAL
Social Links:
Industry:
Finance Financial Exchanges Financial Services FinTech Personal Finance
Founded:
2008-01-01
Status:
Active
Contact:
86-21-61703999
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content ASP.NET IIS IIS 7 Alibaba CNZZ China Unicom
Similar Organizations
cyberplus
cyberplus is a Minamisenju, Arakawa-ku, Tokyo as a company specializing in financial system development.
Current Employees Featured
Liefeng Qu
Liefeng Qu Founder and partner @ New Alliance Capital Founder and partner 2008-01-01
Founder
Liefeng Qu
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-07-29 | Yuntu Semiconductor | New Alliance Capital investment in Series A - Yuntu Semiconductor | N/A |
2022-07-12 | ATAPEX | New Alliance Capital investment in Series A - ATAPEX | 100 M CNY |
2022-04-01 | Lips Semiconductor | New Alliance Capital investment in Series A - Lips Semiconductor | 44 M CNY |
2022-01-11 | NeuroXess | New Alliance Capital investment in Angel Round - NeuroXess | 97 M CNY |
2021-12-31 | Yuntu Semiconductor | New Alliance Capital investment in Series A - Yuntu Semiconductor | 100 M CNY |
2021-12-03 | LePure Biotech | New Alliance Capital investment in Series B - LePure Biotech | N/A |
2021-11-08 | Positive Sequence Biology | New Alliance Capital investment in Series A - Positive Sequence Biology | 300 M CNY |
2021-08-27 | LYNK Pharmaceuticals | New Alliance Capital investment in Series B - LYNK Pharmaceuticals | 50 M USD |
2021-08-18 | MediTrust Health | New Alliance Capital investment in Series C - MediTrust Health | 308 M USD |
2021-05-19 | Synlight Crystal | New Alliance Capital investment in Series D - Synlight Crystal | N/A |